The anticoagulation length of therapy and risk of new adverse events in venous thromboembolism (ALTERNATIVE) study: Design and survey results

The anticoagulation length of therapy and risk of new adverse events in venous thromboembolism (ALTERNATIVE) study: Design and survey results

Show other versions (1)

The Anticoagulation Length of Therapy and Risk of New Adverse Events In Venous Thromboembolism (ALTERNATIVE) study was designed to compare the benefits and harms of different treatment options for extended treatment of venous thromboembolism (VTE). In this paper, we describe the study cohort, survey...

Full description

Bibliographic Details
Main Authors: Cecilia Portugal, Margaret C. Fang, Alan S. Go, Hui Zhou, John Chang, Priya Prasad, Dongjie Fan, Elisha A. Garcia, Sue Hee Sung, Kristi Reynolds
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731472/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731472/?tool=EBI

Similar Items